These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9040309)

  • 1. NSAID gastropathy.
    Yood RA
    Arch Intern Med; 1997 Feb; 157(3):364. PubMed ID: 9040309
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of etodolac, nimesulid and naproxen sodium on the frequency of sister chromatid exchange after enclused third molars surgery.
    Koseoglu BG; Ozturk S; Kocak H; Palanduz S; Cefle K
    Yonsei Med J; 2008 Oct; 49(5):742-7. PubMed ID: 18972594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitor.
    Warner JJ; Weideman RA; Kelly KC; Brilakis ES; Banerjee S; Cunningham F; Harford WV; Kazi S; Little BB; Cryer B
    J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):252-60. PubMed ID: 18787084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric mucosal adaptation to etodolac and naproxen.
    Lipscomb GR; Wallis N; Armstrong G; Goodman MJ; Rees WD
    Aliment Pharmacol Ther; 1995 Aug; 9(4):379-85. PubMed ID: 8527613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic consequences of NSAID-induced gastropathy: the French context.
    de Pouvourville G
    Scand J Rheumatol Suppl; 1992; 96():49-53. PubMed ID: 1439624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastro-intestinal lesions induced by non-steroidal anti-inflammatory drugs.
    Albu R; Dragomir P; Voiosu R
    Rom J Intern Med; 1998; 36(3-4):145-59. PubMed ID: 10822511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etodolac-induced pigmenting fixed drug eruption.
    Ozkaya E; Keles S
    Clin Exp Dermatol; 2007 May; 32(3):332-3. PubMed ID: 17263827
    [No Abstract]   [Full Text] [Related]  

  • 8. Warning of an adverse effect of etodolac.
    Stiles J
    J Am Vet Med Assoc; 2004 Aug; 225(4):503. PubMed ID: 15344353
    [No Abstract]   [Full Text] [Related]  

  • 9. Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolac.
    Melarange R; Gentry C; Blower PR; Toseland CD; Spangler R
    Eur J Rheumatol Inflamm; 1994; 14(2):15-22. PubMed ID: 7744129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: mechanisms and prevention.
    Rich M; Scheiman JM
    Semin Arthritis Rheum; 2000 Dec; 30(3):167-79. PubMed ID: 11124281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances on NSAID and NSAID Gastropathy, 1st annual meeting. Ferrara, Italy, 6-7 December 1996. Proceedings.
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():1-41. PubMed ID: 9132071
    [No Abstract]   [Full Text] [Related]  

  • 12. [The adverse digestive effects of nonsteroidal anti-inflammatory agents. Current physiopathological and clinical aspects. I. The adverse effects on the digestive track].
    Duţu A; Parasca I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1990; 42(2):97-109. PubMed ID: 1982193
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of cyclooxygenase inhibition on the gastrointestinal tract.
    Radi ZA; Khan NK
    Exp Toxicol Pathol; 2006 Nov; 58(2-3):163-73. PubMed ID: 16859903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The side-effects of non-steroidal anti-inflammatory drugs.
    Bardare M; Corona F
    Minerva Pediatr; 1994 Sep; 46(9):359-64. PubMed ID: 7799881
    [No Abstract]   [Full Text] [Related]  

  • 15. [Colonic stenosis secondary to non-steroid anti-inflammatory agents as a cause of anemia and chronic diarrhea].
    Remes-Troche JM; Contreras-Zurita K; Ríos-Luna NP; Sierra-Ascencio M; Valdovinos AM
    Rev Gastroenterol Mex; 2002; 67(4):271-5. PubMed ID: 12653075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic complications of nonsteroidal anti-inflammatory drug use.
    Palmer BF; Henrich WL
    Adv Intern Med; 1996; 41():605-39. PubMed ID: 8903600
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gastrointestinal side effects of non-steroidal anti-inflammatory drugs in high-risk patients--role of selective cyclooxygenase inhibitors].
    Prónai L
    Orv Hetil; 2001 Sep; 142(35):1899-905. PubMed ID: 11601177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C9 polymorphism in non-steroidal anti-inflammatory drugs-induced gastropathy.
    Ma J; Yang XY; Qiao L; Liang LQ; Chen MH
    J Dig Dis; 2008 May; 9(2):79-83. PubMed ID: 18419640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
    Kivitz A; Eisen G; Zhao WW; Bevirt T; Recker DP
    J Fam Pract; 2002 Jun; 51(6):530-7. PubMed ID: 12100776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS
    J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.